Molecular Imaging in Acute Aortic Syndrome: Lighting a Path to Better Risk Assessment
- PMID: 35798406
- DOI: 10.1016/j.jcmg.2022.04.022
Molecular Imaging in Acute Aortic Syndrome: Lighting a Path to Better Risk Assessment
Keywords: acute aortic syndrome; imaging; positron emission tomography.
Conflict of interest statement
Funding Support and Author Disclosures Dr Tawakol is supported in part by U.S. National Institutes of Health #R01HL152957, AR077187, R33HL141047, R01HL149516, and R01HL137913; and has received institutional grant support from Genentech and Lung Biotechnologies for research outside the submitted work. Dr Mezue has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography in Acute Aortic Syndrome.JACC Cardiovasc Imaging. 2022 Jul;15(7):1291-1304. doi: 10.1016/j.jcmg.2022.01.003. Epub 2022 Mar 16. JACC Cardiovasc Imaging. 2022. PMID: 35798405
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
